BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, June 14, 2026
Home » Authors » Cormac Sheridan

Articles by Cormac Sheridan

Grant Provides $109M Start-Up For Danish Proteomics Center

May 2, 2007
By Cormac Sheridan
Proteomics research in Denmark has received a substantial boost - in the form of a DKK600 million (US$109 million) grant from the Novo Nordisk Foundation to establish a new center for protein research at the University of Copenhagen. (BioWorld International)
Read More

MediCult Paying $23M Cash For IVF Diagnostics Company

May 2, 2007
By Cormac Sheridan

LifeCycle Targets U.S. Market With Fenofibrate Partnership

May 2, 2007
By Cormac Sheridan

MediCult Paying $23M Cash For IVF Diagnostics Company

May 2, 2007
By Cormac Sheridan

Grant Provides $109M Start-Up For Danish Proteomics Center

May 2, 2007
By Cormac Sheridan
Proteomics research in Denmark has received a substantial boost - in the form of a DKK600 million (US$109 million) grant from the Novo Nordisk Foundation to establish a new center for protein research at the University of Copenhagen. (BioWorld International)
Read More

International report: Increase sought In Norway’s functional genomics budget

April 26, 2007
By Cormac Sheridan

NiKem Spins Out Brane Discovery For CNS Program

April 25, 2007
By Cormac Sheridan

Increase Sought In Norway's Functional Genomics Budget

April 25, 2007
By Cormac Sheridan
The second phase of the Norwegian Functional Genomics Program (FUGE) has secured NOK420 million (US$70.3 million), which will be allocated to research programs between now and 2011, but the board responsible for the initiative is seeking an additional NOK490 million. An extra NOK45 million is being made available in October to fund industry-driven projects. (BioWorld International)
Read More

Increase Sought In Norway's Functional Genomics Budget

April 25, 2007
By Cormac Sheridan
The second phase of the Norwegian Functional Genomics Program (FUGE) has secured NOK420 million (US$70.3 million), which will be allocated to research programs between now and 2011, but the board responsible for the initiative is seeking an additional NOK490 million. An extra NOK45 million is being made available in October to fund industry-driven projects. (BioWorld International)
Read More

NiKem Spins Out Brane Discovery For CNS Program

April 25, 2007
By Cormac Sheridan
Previous 1 2 … 232 233 234 235 236 237 238 239 240 … 335 336 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 12, 2026.
  • Purple molecules

    Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis

    BioWorld
    Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • 3D illustration of a nerve cell

    Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?

    BioWorld
    Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
  • Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists

    BioWorld Science
    Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing